{"id":"W4412479410","doi":"10.1016/j.jns.2025.123628","title":"First analysis of the Myasthenia Gravis SPOTLIGHT Registry: outcomes with eculizumab and ravulizumab","year":2025,"lang":"en","type":"article","venue":"Journal of the Neurological Sciences","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); University of Toronto","funders":"EMD Serono; National Institutes of Health; Argenx; Alexion Pharmaceuticals; CVS Health; Patient-Centered Outcomes Research Institute; Sanofi; AstraZeneca; Amgen","keywords":"Eculizumab; Myasthenia gravis; Medicine; Pediatrics; Immunology; Antibody; Complement system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037806,0.0002888143,0.0008366614,0.0009059405,0.0001876802,0.0008800745,0.0005498077,0.0003856441,0.001179139],"category_scores_gemma":[0.006077312,0.0001932474,0.0008121034,0.001579048,0.0002159696,0.0007685006,0.0008780784,0.0004666545,0.0003307866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006213963,"about_ca_system_score_gemma":0.0005839844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002704849,"about_ca_topic_score_gemma":0.002931193,"domain_scores_codex":[0.9971764,0.001042253,0.000385149,0.000569808,0.0006099759,0.0002164458],"domain_scores_gemma":[0.9928767,0.00121932,0.004105689,0.0007214838,0.0005400218,0.0005367097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002493012,0.00007794176,0.9914436,0.00006420125,0.0004092192,0.00005674084,0.00005441383,0.0002070048,0.0002247626,0.00004481162,0.0007786267,0.004145654],"study_design_scores_gemma":[0.0002496297,0.0004874832,0.997834,0.000013679,0.000213315,0.0001446036,0.00005731717,0.0003317882,0.0001313048,0.00001532238,0.0005149995,0.000006441624],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916708,0.0006599937,0.0001838404,0.00009406407,0.000007802101,0.0000661891,0.006245043,0.00001669673,0.0010556],"genre_scores_gemma":[0.9880025,0.0001837256,0.0001883823,0.00006310727,0.00002427604,0.00008219326,0.01128688,0.00001056502,0.0001584321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0037806,"threshold_uncertainty_score":0.01999396,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01238224602966141,"score_gpt":0.2636445985500859,"score_spread":0.2512623525204245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}